Quality of life after balloon angioplasty or stenting for acute myocardial infarction

Rinfret, Stéphane; Grines, Cindy L.; Cosgrove, Roberta S.; Ho, Kalon K.L.; Cox, David A.; Brodie, Bruce R.; Morice, Marie‐Claude; Stone, Gregg W.; Cohen, David J.

doi:10.1016/s0735-1097(01)01599-6

Cited by 65 publications

(49 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The reason for the lack of association between Type D and physical functioning may be that for this sub domain, baseline health status had a considerably larger impact (26-fold) than for any of the other sub domains (ranging from 5-to 9-fold). Improvement in health status over time following revascularization is consistent with other studies post-CABG [10] and PCI [28] indicating the beneficial effects of revascularization on health status. However, in the current study we showed that subgroups of patients may not benefit from PCI on par with other patients, as Type D patients experienced significantly impaired health status compared with non-Type D patients.…”

Section: Discussionsupporting

confidence: 89%

Impaired health status in Type D patients following PCI in the drug-eluting stent era

Pedersen¹,

Denollet²,

Ong³

et al. 2007

International Journal of Cardiology

View full text Add to dashboard Cite

Background: Drug-eluting stenting reduces restenosis post-percutaneous coronary intervention (PCI), but subgroups of patients may not benefit optimally from this procedure. We examined the impact of Type D personality on health status over time and the clinical relevance of Type D as a predictor of impaired health status at 12 months in unselected post-PCI patients. Methods: Consecutive patients (n = 692) participating in the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry completed the Type D Scale at 6 months and the Short Form Health Survey 36 (SF-36) at 6 and 12 months post-PCI. Results: Although there was a significant improvement in health status over time ( p < 0.001), Type D patients reported a substantially lower score on all health status domains of the SF-36 compared with non-Type D patients ( p < 0.001). Type D personality was an independent predictor of impaired health status on all SF-36 sub domains at 12 months except for physical functioning, adjusting for baseline demographic and clinical variables and health status at 6 months. In these adjusted analyses, Type D personality increased the likelihood of impaired health status at 12 months post-PCI from 60% (OR: 1.60; 95% CI: 1.04 -2.46) to almost 300% (OR: 3.99; 95% CI: 2.52 -6.32), varying among the parameters analyzed. Conclusions: Type D personality was associated with impaired health status in post-PCI patients treated in the drug-eluting stent era. The role of personality factors as determinants of clinical outcome and health status should not be overlooked as these factors may have much explanatory power. D

show abstract

Section: Discussionsupporting

confidence: 89%

Impaired health status in Type D patients following PCI in the drug-eluting stent era

Pedersen¹,

Denollet²,

Ong³

et al. 2007

International Journal of Cardiology

View full text Add to dashboard Cite

show abstract

“…Bulgularımız KA+PTCA+stent uygulamasının hemen tüm boyutlarda iyileşmeye (yüksek puan=kötü yaşam kalitesi) yol açarken, KA uygulamasına göre sadece duygusal tepki boyutunu anlamlı düzeyde olumlu etkilediğini ortaya koymuştur. Koroner anjiyoplastinin yaşam kalitesi üzerindeki olumlu etkisi diğer bazı çalış-malarda da gösterilmiştir (49,50). Bu durum girişimin psikolojik yönden olumlu etkisi olarak değerlendirilebilir.…”

Section: Discussionunclassified

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

Yılmaz¹,

Eser²,

Seküri³

et al. 2011

Anadolu Kardiyol Derg

View full text Add to dashboard Cite

Objective: The purpose of this study was to describe the psychometric properties of the Myocardial Infarction Dimensional Assessment Scale (MIDAS). Methods: This is a methodological cultural adaptation study. The MIDAS consists of 35-items covering seven domains: physical activity, insecurity, emotional reaction, dependency, diet, concerns over medication, and side effects which are rated on a five-point Likert scale from 1: never to 5:always. The highest score of MIDAS is 100.Quality of life (QOL) decreases as the score of scale increases. Overall 185 myocardial infarction (MI) patients were enrolled in this study. Cronbach alpha was used for the reliability analysis. The criterion validity, structural validity, and sensitivity analysis approach was used for validity analysis. New York Heart Association (NYHA) and the Canadian Cardiovascular Society Functional Classifications (CCSFC) for testing the criterion validity; SF-36 for construct validity testing of the Turkish version of the MIDAS were used.

show abstract

“…In a prospective substudy of the Stent-Primary Angioplasty for Acute Myocardial Infarction (Stent-PAMI) trial, Rinfret and colleagues 182 reported that compared with conventional balloon angioplasty, initial stent placement was associated with significantly better HRQoL at 6-month follow-up but no differences at 1 year. These differences were primarily explained by the reduced rates of angiographic and clinical restenosis associated with stenting.…”

Section: Quality Of Life Datamentioning

confidence: 99%

Coronary artery stents: a rapid systematic review and economic evaluation

Hill¹,

Bagust²,

Bakhai³

et al. 2004

Health Technol Assess

144

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public...

show abstract

Quality of life after balloon angioplasty or stenting for acute myocardial infarction

Cited by 65 publications

References 22 publications

Impaired health status in Type D patients following PCI in the drug-eluting stent era

Impaired health status in Type D patients following PCI in the drug-eluting stent era

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

Coronary artery stents: a rapid systematic review and economic evaluation

Contact Info

Product

Resources

About